Nine Chapters Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,167
Closed -$140K 207
2017
Q1
$140K Buy
1,167
+504
+76% +$52.5K 0.19% 182
2016
Q4
$65K Buy
663
+120
+22% +$11K 0.11% 153
2016
Q3
$51K Buy
+543
New +$54.4K 0.36% 64
2015
Q4
Sell
-2,463
Closed -$420K 659
2015
Q3
$420K Sell
2,463
-800
-25% -$153K 0.04% 621
2015
Q2
$632K Buy
3,263
+1,543
+90% +$286K 0.05% 494
2015
Q1
$255K Buy
1,720
+577
+50% +$87.9K 0.02% 772
2014
Q4
$178K Buy
1,143
+133
+13% +$19.2K 0.02% 809
2014
Q3
$145K Buy
1,010
+397
+65% +$57.6K 0.01% 898
2014
Q2
$80K Buy
+613
New +$77.9K 0.01% 889

Other funds holding SRGA

Nine Chapters Capital Management's SRGA Position: Q2 2017 in Review

Nine Chapters Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2017, closing a stake of 1,167 shares — an estimated $140K sold.

Nine Chapters Capital Management first reported a position in SRGA in Q2 2014 and held it in 9 quarters. The position peaked at $632K in Q2 2015. 107 funds tracked by Wall St. Rank hold SRGA as of Q2 2017.

  • Nine Chapters Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Nine Chapters Capital Management sold 1,167 Surgalign Holdings, Inc. Common Stock shares in Q2 2017, an estimated $140K.
  • Nine Chapters Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2014 and held it in 9 quarters.
  • Nine Chapters Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $632K in Q2 2015.
  • 107 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2017.

Based on Nine Chapters Capital Management's 13F filing for Q2 2017, filed 31 Jul 2017.